Clinical Trial Update: Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of zoledronic acid for preventing and treating corticosteroid-induced osteoporosis; the study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corticosteroid-induced Osteoporosis
• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED